LYFAX | VHCIX | LYFAX / VHCIX | |
Total Expense Ratio | 1.66 | 0.09 | 1,844% |
Annual Report Gross Expense Ratio | 1.91 | 0.09 | 2,122% |
Fund Existence | 6 years | 22 years | - |
Gain YTD | 1.038 | -0.269 | -386% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 33.2M | 17B | 0% |
Annual Yield % from dividends | 2.08 | 1.65 | 126% |
Returns for 1 year | -4.48 | -9.58 | 47% |
Returns for 3 years | -6.28 | 1.50 | -420% |
Returns for 5 years | 17.39 | 23.54 | 74% |
Returns for 10 years | N/A | 77.75 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HELX | 29.58 | 0.21 | +0.73% |
Franklin Genomic Advancements ETF | |||
IDOG | 36.00 | 0.23 | +0.64% |
ALPS International Sector Div Dogs ETF | |||
MGF | 3.12 | 0.01 | +0.32% |
MFS Government Markets Income Trust | |||
PMMF | 100.36 | 0.03 | +0.03% |
iShares Prime Money Market ETF | |||
FXO | 57.58 | -0.74 | -1.27% |
First Trust Financials AlphaDEX® ETF |